FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May. 11, 2009-- MEDNAX, Inc., (NYSE: MD) has completed the acquisition of a physician group practice that provides neonatal intensive care and well-baby care at five hospitals throughout the Houston, Texas, metropolitan area.

Houston Neonatal-Perinatal Physicians is a 12-physician practice that provides care at three hospitals with Level III neonatal intensive care units (NICU), and two hospitals with Level II units. Annual combined patient volume exceeds 21,000 NICU days, and more than 14,000 well-baby patient days.

The group, which has more than 25 years of continuous patient care in the Houston community, will provide services as part of Pediatrix Medical Group, MEDNAX’s operating unit focused on neonatal, maternal-fetal, pediatric subspecialty and newborn hearing screens.

“We’ve experienced strong growth in recent years by focusing on managing our relationships with our hospital partners and referring obstetricians to grow our practice, and we’re looking forward to a lot of the administrative support that Pediatrix will provide to our clinical team,” said William Caplan, M.D., who will serve as Pediatrix’s medical director for the practice. “We’re also hoping that by accessing some of Pediatrix’s continuing education and clinical quality programs we’ll add more resources to our existing efforts to identify ways to constantly improve patient care.”

MEDNAX paid cash for the Houston neonatal practice, which is expected to contribute to earnings immediately. No additional terms were disclosed.

During 2009, MEDNAX has completed four physician group practice acquisitions, including three neonatal practices and one pediatric cardiology practice.

About MEDNAX

MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,275 physicians in 32 states and Puerto Rico. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors,” as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

MEDNAX, Inc.
Bob Kneeley, 954-384-0175, x-5300
Director, Investor Relations
bob_kneeley@mednax.com